|
Status |
Public on Oct 22, 2019 |
Title |
hCMEC/D3 cell line with single atorvastatin,single dexamethasone or low-dexamenthasone and atorvastatin treatment after hematoma injuried |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Some studies have revealed that treating chronic subdural hematoma (CSDH) with drugs is effective; however, the specific mechanism of this process has been seldom discussed. Herein, we sought to identify the potential underlying mechanism of atorvastatin and low-dose dexamethasone for CSDH treatment. We sequenced the hCMEC/D3 cell lines treated with single statin, dexamethasone and low dose dexamethasone after hematoma injuried and statin to find out the key point.
|
|
|
Overall design |
sham group, hematoma stimulation group, single atorvastatin treatment group, single dexamethasone treatment, and combination treatment group.
|
|
|
Contributor(s) |
Wang D, Wang B |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Oct 21, 2019 |
Last update date |
Oct 22, 2019 |
Contact name |
Yueshan Fan |
E-mail(s) |
fanyueshan@hotmail.com
|
Phone |
+86 15122590841
|
Organization name |
Tianjin Medical University General Hospital
|
Street address |
154 Anshan Road, Tianjin, China
|
City |
Tianjin |
ZIP/Postal code |
3000000 |
Country |
China |
|
|
Platforms (1) |
GPL27644 |
Illumina Novaseq 6000 (Homo sapiens) |
|
Samples (10)
|
|
Relations |
BioProject |
PRJNA578611 |
SRA |
SRP226410 |